LOXL4 and lung cancer: Accumulating evidence suggest LOXL4 an oncoprotein in several tumors, such as hepatocellular carcinoma (Li et al., 2019), lung cancer (Zhang et al., 2019) and breast cancer (Choi et al., 2017).